1. Home
  2. RCEL vs APPS Comparison

RCEL vs APPS Comparison

Compare RCEL & APPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCEL
  • APPS
  • Stock Information
  • Founded
  • RCEL N/A
  • APPS 2007
  • Country
  • RCEL United States
  • APPS United States
  • Employees
  • RCEL N/A
  • APPS N/A
  • Industry
  • RCEL Medical/Dental Instruments
  • APPS Multi-Sector Companies
  • Sector
  • RCEL Health Care
  • APPS Miscellaneous
  • Exchange
  • RCEL Nasdaq
  • APPS Nasdaq
  • Market Cap
  • RCEL 227.5M
  • APPS 243.8M
  • IPO Year
  • RCEL N/A
  • APPS N/A
  • Fundamental
  • Price
  • RCEL $9.21
  • APPS $3.12
  • Analyst Decision
  • RCEL Strong Buy
  • APPS Hold
  • Analyst Count
  • RCEL 4
  • APPS 4
  • Target Price
  • RCEL $17.25
  • APPS $2.38
  • AVG Volume (30 Days)
  • RCEL 201.7K
  • APPS 3.3M
  • Earning Date
  • RCEL 05-08-2025
  • APPS 05-27-2025
  • Dividend Yield
  • RCEL N/A
  • APPS N/A
  • EPS Growth
  • RCEL N/A
  • APPS N/A
  • EPS
  • RCEL N/A
  • APPS N/A
  • Revenue
  • RCEL $64,251,000.00
  • APPS $483,577,000.00
  • Revenue This Year
  • RCEL $62.33
  • APPS N/A
  • Revenue Next Year
  • RCEL $30.59
  • APPS $6.49
  • P/E Ratio
  • RCEL N/A
  • APPS N/A
  • Revenue Growth
  • RCEL 28.14
  • APPS N/A
  • 52 Week Low
  • RCEL $6.90
  • APPS $1.18
  • 52 Week High
  • RCEL $14.16
  • APPS $6.86
  • Technical
  • Relative Strength Index (RSI)
  • RCEL 56.76
  • APPS 53.23
  • Support Level
  • RCEL $8.15
  • APPS $3.24
  • Resistance Level
  • RCEL $9.36
  • APPS $2.85
  • Average True Range (ATR)
  • RCEL 0.67
  • APPS 0.35
  • MACD
  • RCEL 0.15
  • APPS 0.06
  • Stochastic Oscillator
  • RCEL 93.90
  • APPS 94.39

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the US with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

About APPS Digital Turbine Inc.

Digital Turbine Inc is an independent mobile growth platform. It offers end-to-end products and solutions to all participants in the mobile application ecosystem, enabling brand discovery and advertising, user acquisition and engagement, and operational efficiency for advertisers. Its operating segments are On Device Solutions and App Growth Platform.

Share on Social Networks: